Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dimitrios Zisopoulos"'
Autor:
Constantinos Stefanis, Dimitrios Oikonomou, Grigorios T. Sakellariou, Athina Pyrpasopoulou, Charalambos Bermperidis, Periklis Vounotrypidis, Dimitrios Zisopoulos, Periklis Pappas, Nikoleta Kefala, Spyros Aslanidis
Publikováno v:
Clinical Rheumatology. 38:2925-2932
Clinical recognition of vascular acrosyndromes is often challenging. The term Raynaud's phenomenon (RP) is commonly overused to describe any form of cold-related disorder. This study aims to formally evaluate peripheral vascular symptoms affecting th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3819a253667b51036d5097d854ca3a93
https://doi.org/10.1007/s10067-019-04627-w
https://doi.org/10.1007/s10067-019-04627-w
Autor:
Ioannis Papadopoulos, Pierre Geborek, Theodora E. Markatseli, A. Iliopoulos, Dimitrios Zisopoulos, Kyriaki A. Boki, Paraskevi V. Voulgari, Irini Flouri, Alexandros A. Drosos, Fotini N. Skopouli, Dimitrios T. Boumpas, Loukas Settas, Prodromos Sidiropoulos
Publikováno v:
The Journal of rheumatology. 45(6)
Objective.To evaluate the 10-year drug survival of the first tumor necrosis factor inhibitor (TNFi) administered to patients with spondyloarthritis (SpA) overall and comparatively between SpA subsets, and to identify predictors of drug retention.Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b96d9059832775b0afe06ab2b39e82e
https://pubmed.ncbi.nlm.nih.gov/29606666
https://pubmed.ncbi.nlm.nih.gov/29606666
Autor:
Ioannis Papadopoulos, George Bertsias, Dimitrios Zisopoulos, Prodromos Sidiropoulos, Paraskevi V. Voulgari, Irini Flouri, Dimitrios T. Boumpas, A. Iliopoulos, Kyriaki A. Boki, Fotini N. Skopouli, Pierre Geborek, Theodora E. Markatseli, Loukas Settas, Alexandros A. Drosos
Publikováno v:
Seminars in Arthritis and Rheumatism. 43:447-457
Objective: To compare effectiveness, drug survival, and safety between infliximab, adalimumab, and etanercept, in a nationwide cohort of rheumatoid arthritis (RA) patients. Methods: This study is a prospective cohort study of 1208 active RA patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d6905a97371e3ec7932b8aca5db94ed
https://doi.org/10.1016/j.semarthrit.2013.07.011
https://doi.org/10.1016/j.semarthrit.2013.07.011
Autor:
Nadia, Boubouchairopoulou, Irini, Flouri, Alexandros A, Drosos, Kyriaki, Boki, Loukas, Settas, Dimitrios, Zisopoulos, Fotini N, Skopouli, Ioannis, Papadopoulos, Alexios, Iliopoulos, John, Kyriopoulos, Dimitrios T, Boumpas, Konstantinos, Athanasakis, Prodromos, Sidiropoulos
Publikováno v:
Clinical and experimental rheumatology. 34(6)
To assess in daily practice in patients with rheumatoid arthritis (RA) the effect of treatment with first tumour necrosis factor-α inhibitor (TNFi) in quality of life (Qol), disease activity and depict possible baseline predictors for gains in Qol.P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::94f8c4d9002885e8719b91d536bef797
https://pubmed.ncbi.nlm.nih.gov/27749220
https://pubmed.ncbi.nlm.nih.gov/27749220
Publikováno v:
LCN
The DiffServ architecture provides a scalable mechanism for QoS introduction in a TCP/IP network. DiffServ model is based on the aggregation of traffic flows at an ingress (or egress) point of a network and the IP packet marking for different priorit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1174722e20b94a972cd48dc92072a590
https://doi.org/10.1109/lcn.2006.322167
https://doi.org/10.1109/lcn.2006.322167